Dieulafoy’s lesion is an arterial malformation in the subumucosal layer of the gastrointestinal tract that can cause massive bleeding. The esophagus is not a common location for this lesion. We present here a first report of Dieulafoy’s lesion of the esophagus correctly diagnosed and successfully treated by the endoscopic injection of N-butyl-2-cyanoacrylate.
References
-
1
Dieulafoy G.
Exulceratio simplex.
Bull Acad Med.
1898;
39
49-84
-
2
Juler G L, Labitzke H G, Lamb R, Allen R.
The pathogenesis of Dieulafoy’s gastric erosion.
Am J Gastroenterol.
1984;
79
195-200
-
3
Ikeda Y, Tamakawa R, Hatakeyama H. et al .
Evaluation of endoscopic local injection of hypertonic saline-epinephrine solution and surgical treatment on hemorrhagic gastroduodenal ulcer.
Nippon Geka Gakkai Zasshi.
1989;
90
1545-1547 [In Japanese]
-
4
Kasapidis P, Georgopoulos P, Delis V, Balatsos V. et al .
Endoscopic management and long-term follow-up of Dieulafoy’s lesions in the upper GI tract.
Gastrointest Endosc.
2002;
55
527-531
-
5
Ertekin C, Barbaros U, Taviloglu K. et al .
Dieulafoy’s lesion of esophagus.
Surg Endosc.
2002;
16
219
-
6
Iso Y, Kawanaka H, Tomikawa M. et al .
Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices: a prospective randomized trial.
Hepatogastroenterology.
1997;
44
467-471
-
7
Soehendra N, Grimm H, Nam V C. et al .
N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy.
Endoscopy.
1987;
19
221-224
-
8
Sheikh R A, Trudeau W L.
Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding.
Gastrointest Endosc.
2000;
52
142-144
T. Yoshida, M. D., Ph. D.
Molecular Science and Applied Medicine, Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine
1-1-1 Minami-Kogushi · Ube · Yamaguchi 755-8505 · Japan
Fax: + 81-836-222240
Email: tyoshida@yamaguchi-u.ac.jp
